Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02278718 · ClinicalTrials.gov registry record · Phase 3
A Study to Evaluate the Efficacy and Safety of NexoBrid in Children With Thermal Burns Compared the Standard of Care
A Phase 3 study, sponsored by MediWound.
- Completed
- Registry status
- Phase 3
- Development phase
- 145
- Enrollment target
NCT02278718 is a Phase 3 study that has completed, run by MediWound. The registered enrollment target is 145 participants.
The verdict
NCT02278718, a Phase 3 study, has completed, sponsored by MediWound.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 145 participants
- Enrollment target
Study Summary
This study will be a two-arms study intending to demonstrate superiority of NexoBrid treatment over SOC in children with thermal burns. The study objective is to evaluate the safety and clinical benefit of NexoBrid in hospitalized children (0-17 years) with deep partial and/or full thickness thermal burns of 1-30% TBSA and to compare NexoBrid to standard of care (SOC).
Interventions
- PROCEDURE Standard of Care
- DRUG NexoBrid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 145 participants |
| Start Date | 2015-05 |
| Est. Completion | 2022-12 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02278718
The ClinicalTrials.gov registry entry for NCT02278718 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 145 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is MediWound, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Standard of Care is the first listed.
NCT02278718 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02278718 about?
NCT02278718 is a clinical study titled "A Study to Evaluate the Efficacy and Safety of NexoBrid in Children With Thermal Burns Compared the Standard of Care". This study will be a two-arms study intending to demonstrate superiority of NexoBrid treatment over SOC in children with thermal burns. The study objective is to evaluate the safety and clinical benefit of NexoBrid in hospitalized children (0-17 years) with deep partial and/or full thickness thermal...
What is the current status of trial NCT02278718?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 145 participants. The study started on 2015-05. Estimated completion is 2022-12.
What interventions are being tested in trial NCT02278718?
The interventions under investigation include: Standard of Care (PROCEDURE), NexoBrid (DRUG).
Who is sponsoring clinical trial NCT02278718?
This trial is sponsored by MediWound, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.